Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adelaide S Robb

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Journal of Child and Adolescent Psychopharmacology|February 20, 2010
Changes in positive and negative syndrome scale-derived hostility factor in adolescents with schizophrenia treated with aripiprazole: post hoc analysis of randomized clinical trial dataAdelaide S Robb, William H Carson, Margaretta Nyilas, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 14, 2005
Dopamine transporter genotype and methylphenidate dose response in children with ADHDMark A Stein, Irwin D Waldman, Christopher S Sarampote, et al.
Journal of Child and Adolescent Psychopharmacology|April 29, 2015
Child and adolescent psychiatrists' reported monitoring behaviors for second-generation antipsychoticsAngie Mae Rodday, Susan K Parsons, Catherine Mankiw, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|January 10, 2008
Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysisW Burleson Daviss, Nick C Patel, Adelaide S Robb, et al.
Pediatrics|November 5, 2003
A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorderMark A Stein, Christopher S Sarampote, Irwin D Waldman, et al.
Journal of Child and Adolescent Psychopharmacology|August 28, 2019
Maladaptive Aggression: With a Focus on Impulsive Aggression in Children and AdolescentsDaniel F Connor, Jeffrey H Newcorn, Keith E Saylor, et al.
Journal of Child and Adolescent Psychopharmacology|March 24, 2017
Pharmacokinetics and Safety of Vortioxetine in Pediatric PatientsRobert L Findling, Adelaide S Robb, Melissa DelBello, et al.
Hospital Pediatrics|September 15, 2020
Improving Youth Suicide Risk Screening and Assessment in a Pediatric Hospital Setting by Using The Joint Commission GuidelinesFinza Latif, Shilpa Patel, Gia Badolato, et al.
Journal of Child and Adolescent Psychopharmacology|August 2, 2019
A Novel Assessment Tool for Impulsive Aggression in Children with Attention-Deficit/Hyperactivity DisorderGianpiera Ceresoli-Borroni, Tesfaye Liranso, Scott T Brittain, et al.
Journal of Child and Adolescent Psychopharmacology|October 17, 2017
A 6-Month Open-Label Extension Study of Vortioxetine in Pediatric Patients with Depressive or Anxiety DisordersRobert L Findling, Adelaide S Robb, Melissa P DelBello, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Journal of Child and Adolescent Psychopharmacology|February 20, 2010
Changes in positive and negative syndrome scale-derived hostility factor in adolescents with schizophrenia treated with aripiprazole: post hoc analysis of randomized clinical trial dataAdelaide S Robb, William H Carson, Margaretta Nyilas, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 14, 2005
Dopamine transporter genotype and methylphenidate dose response in children with ADHDMark A Stein, Irwin D Waldman, Christopher S Sarampote, et al.
Journal of Child and Adolescent Psychopharmacology|April 29, 2015
Child and adolescent psychiatrists' reported monitoring behaviors for second-generation antipsychoticsAngie Mae Rodday, Susan K Parsons, Catherine Mankiw, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|January 10, 2008
Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysisW Burleson Daviss, Nick C Patel, Adelaide S Robb, et al.
Pediatrics|November 5, 2003
A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorderMark A Stein, Christopher S Sarampote, Irwin D Waldman, et al.
Journal of Child and Adolescent Psychopharmacology|August 28, 2019
Maladaptive Aggression: With a Focus on Impulsive Aggression in Children and AdolescentsDaniel F Connor, Jeffrey H Newcorn, Keith E Saylor, et al.
Journal of Child and Adolescent Psychopharmacology|March 24, 2017
Pharmacokinetics and Safety of Vortioxetine in Pediatric PatientsRobert L Findling, Adelaide S Robb, Melissa DelBello, et al.
Hospital Pediatrics|September 15, 2020
Improving Youth Suicide Risk Screening and Assessment in a Pediatric Hospital Setting by Using The Joint Commission GuidelinesFinza Latif, Shilpa Patel, Gia Badolato, et al.
Journal of Child and Adolescent Psychopharmacology|August 2, 2019
A Novel Assessment Tool for Impulsive Aggression in Children with Attention-Deficit/Hyperactivity DisorderGianpiera Ceresoli-Borroni, Tesfaye Liranso, Scott T Brittain, et al.
Journal of Child and Adolescent Psychopharmacology|October 17, 2017
A 6-Month Open-Label Extension Study of Vortioxetine in Pediatric Patients with Depressive or Anxiety DisordersRobert L Findling, Adelaide S Robb, Melissa P DelBello, et al.
Pageof 4